{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T07:00:28Z","timestamp":1791356428385,"version":"4.3.1"},"reference-count":118,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ajkd.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Kidney Diseases"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1053\/j.ajkd.2026.01.021","type":"journal-article","created":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T16:27:20Z","timestamp":1782145640000},"page":"439-453","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Mitochondrial Alterations and CKD: A Review"],"prefix":"10.1053","volume":"88","author":[{"given":"Jairo A.","family":"Pinzon-Cortes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Phoom","family":"Narongkiatikhun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Long","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaroslawna","family":"Meister","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hailey","family":"Hampson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dani\u00ebl","family":"van Raalte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denis P.","family":"Blondin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megan","family":"Capozzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian R.","family":"Sweet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert G.","family":"Nelson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karin","family":"Jandeleit-Dahm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josephine M.","family":"Forbes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark E.","family":"Cooper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petter","family":"Bjornstad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1053\/j.ajkd.2026.01.021_bib1","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1038\/s41581-024-00820-6","article-title":"Chronic kidney disease and the global public health agenda: an international consensus","volume":"20","author":"Francis","year":"2024","journal-title":"Nat Rev Nephrol"},{"issue":"9888","key":"10.1053\/j.ajkd.2026.01.021_bib2","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/S0140-6736(13)60687-X","article-title":"Chronic kidney disease: global dimension and perspectives","volume":"382","author":"Jha","year":"2013","journal-title":"Lancet"},{"issue":"3","key":"10.1053\/j.ajkd.2026.01.021_bib3","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.3390\/ijms23031776","article-title":"Mitochondrial pathophysiology on chronic kidney disease","volume":"23","author":"Braga","year":"2022","journal-title":"Int J Mol Sci"},{"issue":"5","key":"10.1053\/j.ajkd.2026.01.021_bib4","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1016\/j.kint.2017.05.034","article-title":"The hallmarks of mitochondrial dysfunction in chronic kidney disease","volume":"92","author":"Galvan","year":"2017","journal-title":"Kidney Int"},{"issue":"12","key":"10.1053\/j.ajkd.2026.01.021_bib5","doi-asserted-by":"crossref","first-page":"3386","DOI":"10.1016\/j.ekir.2024.09.019","article-title":"Unraveling diabetic kidney disease: the roles of mitochondrial dysfunction and immunometabolism","volume":"9","author":"Narongkiatikhun","year":"2024","journal-title":"Kidney Int Rep"},{"issue":"2","key":"10.1053\/j.ajkd.2026.01.021_bib6","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1177\/1479164114561992","article-title":"Probing SGLT2 as a therapeutic target for diabetes: basic physiology and consequences","volume":"12","author":"Gallo","year":"2015","journal-title":"Diab Vasc Dis Res"},{"issue":"1","key":"10.1053\/j.ajkd.2026.01.021_bib7","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s12551-015-0186-2","article-title":"Glucose transporters: physiological and pathological roles","volume":"8","author":"Navale","year":"2016","journal-title":"Biophys Rev"},{"issue":"4","key":"10.1053\/j.ajkd.2026.01.021_bib8","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1681\/ASN.2021050680","article-title":"Decreased renal gluconeogenesis is a hallmark of chronic kidney disease","volume":"33","author":"Verissimo","year":"2022","journal-title":"J Am Soc Nephrol"},{"issue":"8","key":"10.1053\/j.ajkd.2026.01.021_bib9","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1681\/ASN.0000000000000156","article-title":"PCK1 protects against mitoribosomal defects in diabetic nephropathy in mouse models","volume":"34","author":"Hasegawa","year":"2023","journal-title":"J Am Soc Nephrol"},{"issue":"6","key":"10.1053\/j.ajkd.2026.01.021_bib10","doi-asserted-by":"crossref","first-page":"F532","DOI":"10.1152\/ajprenal.00038.2023","article-title":"PCK1 is a key regulator of metabolic and mitochondrial functions in renal tubular cells","volume":"324","author":"Verissimo","year":"2023","journal-title":"Am J Physiol Renal Physiol"},{"issue":"5","key":"10.1053\/j.ajkd.2026.01.021_bib11","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/j.kint.2025.06.018","article-title":"Phosphoenolpyruvate carboxykinase 1-mediated cataplerosis is required to maintain mitochondrial fitness and to avoid kidney disease progression","volume":"108","author":"Dalga","year":"2025","journal-title":"Kidney Int"},{"issue":"7","key":"10.1053\/j.ajkd.2026.01.021_bib12","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1038\/sj.ki.5000207","article-title":"Mitochondrial dysfunction in focal segmental glomerulosclerosis of puromycin aminonucleoside nephrosis","volume":"69","author":"Hagiwara","year":"2006","journal-title":"Kidney Int"},{"issue":"11","key":"10.1053\/j.ajkd.2026.01.021_bib13","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1038\/s41581-018-0051-1","article-title":"Metabolism and mitochondria in polycystic kidney disease research and therapy","volume":"14","author":"Padovano","year":"2018","journal-title":"Nat Rev Nephrol"},{"issue":"9","key":"10.1053\/j.ajkd.2026.01.021_bib14","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1681\/ASN.0000000000000177","article-title":"Fetal reprogramming of nutrient surplus signaling, O-GlcNAcylation, and the evolution of CKD","volume":"34","author":"Packer","year":"2023","journal-title":"J Am Soc Nephrol"},{"issue":"5","key":"10.1053\/j.ajkd.2026.01.021_bib15","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1038\/nrneph.2018.9","article-title":"Mitochondrial dysfunction in diabetic kidney disease","volume":"14","author":"Forbes","year":"2018","journal-title":"Nat Rev Nephrol"},{"issue":"2","key":"10.1053\/j.ajkd.2026.01.021_bib16","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1111\/jcmm.17116","article-title":"Mitochondrial dynamics and diabetic kidney disease: missing pieces for the puzzle of therapeutic approaches","volume":"26","author":"Narongkiatikhun","year":"2022","journal-title":"J Cell Mol Med"},{"issue":"23","key":"10.1053\/j.ajkd.2026.01.021_bib17","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.132826","article-title":"Mitophagy-dependent macrophage reprogramming protects against kidney fibrosis","volume":"4","author":"Bhatia","year":"2019","journal-title":"JCI Insight"},{"issue":"9","key":"10.1053\/j.ajkd.2026.01.021_bib18","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1042\/CS20150838","article-title":"Mapping time-course mitochondrial adaptations in the kidney in experimental diabetes","volume":"130","author":"Coughlan","year":"2016","journal-title":"Clin Sci (Lond)"},{"issue":"5","key":"10.1053\/j.ajkd.2026.01.021_bib19","doi-asserted-by":"crossref","first-page":"6493","DOI":"10.1096\/fj.201901739RR","article-title":"Increased mitochondrial fragmentation in polycystic kidney disease acts as a modifier of disease progression","volume":"34","author":"Cassina","year":"2020","journal-title":"FASEB J"},{"issue":"4","key":"10.1053\/j.ajkd.2026.01.021_bib20","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1159\/000530344","article-title":"Therapeutic potential targeting podocyte mitochondrial dysfunction in focal segmental glomerulosclerosis","volume":"9","author":"Li","year":"2023","journal-title":"Kidney Dis (Basel)"},{"issue":"3","key":"10.1053\/j.ajkd.2026.01.021_bib21","doi-asserted-by":"crossref","first-page":"728","DOI":"10.2337\/db11-0584","article-title":"Catalase deficiency accelerates diabetic renal injury through peroxisomal dysfunction","volume":"61","author":"Hwang","year":"2012","journal-title":"Diabetes"},{"issue":"7","key":"10.1053\/j.ajkd.2026.01.021_bib22","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.1921828118","article-title":"The mitochondrial thioredoxin reductase system (TrxR2) in vascular endothelium controls peroxynitrite levels and tissue integrity","volume":"118","author":"Kameritsch","year":"2021","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6","key":"10.1053\/j.ajkd.2026.01.021_bib23","doi-asserted-by":"crossref","DOI":"10.1111\/acel.13154","article-title":"Glutathione peroxidase-1 overexpression reduces oxidative stress, and improves pathology and proteome remodeling in the kidneys of old mice","volume":"19","author":"Chu","year":"2020","journal-title":"Aging Cell"},{"issue":"2","key":"10.1053\/j.ajkd.2026.01.021_bib24","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.kint.2016.02.043","article-title":"Challenging the dogma of mitochondrial reactive oxygen species overproduction in diabetic kidney disease","volume":"90","author":"Coughlan","year":"2016","journal-title":"Kidney Int"},{"issue":"10","key":"10.1053\/j.ajkd.2026.01.021_bib25","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1681\/ASN.2012111112","article-title":"NADPH oxidases, reactive oxygen species, and the kidney: friend and foe","volume":"24","author":"Sedeek","year":"2013","journal-title":"J Am Soc Nephrol"},{"issue":"7","key":"10.1053\/j.ajkd.2026.01.021_bib26","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a015008","article-title":"Mitochondrial biogenesis through activation of nuclear signaling proteins","volume":"5","author":"Dominy","year":"2013","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"10.1053\/j.ajkd.2026.01.021_bib27","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1007\/978-1-0716-3179-9_18","article-title":"Assessment of kidney mitochondrial function by high-resolution respirometry, transmission electron microscopy, and histological techniques","volume":"2664","author":"Orozco-Ibarra","year":"2023","journal-title":"Methods Mol Biol"},{"issue":"2","key":"10.1053\/j.ajkd.2026.01.021_bib28","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1038\/nprot.2014.018","article-title":"Comprehensive measurement of respiratory activity in permeabilized cells using extracellular flux analysis","volume":"9","author":"Salabei","year":"2014","journal-title":"Nat Protoc"},{"issue":"25","key":"10.1053\/j.ajkd.2026.01.021_bib29","article-title":"Measuring mitochondrial function in permeabilized cells using the seahorse XF analyzer or a Clark-type oxygen electrode","volume":"60","author":"Divakaruni","year":"2014","journal-title":"Curr Protoc Toxicol"},{"issue":"8","key":"10.1053\/j.ajkd.2026.01.021_bib30","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1038\/s42255-022-00619-4","article-title":"A practical guide for the analysis, standardization and interpretation of oxygen consumption measurements","volume":"4","author":"Divakaruni","year":"2022","journal-title":"Nat Metab"},{"issue":"4","key":"10.1053\/j.ajkd.2026.01.021_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2021.101140","article-title":"From OCR and ECAR to energy: perspectives on the design and interpretation of bioenergetics studies","volume":"297","author":"Schmidt","year":"2021","journal-title":"J Biol Chem"},{"issue":"1","key":"10.1053\/j.ajkd.2026.01.021_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.xpro.2021.100386","article-title":"Protocol to profile the bioenergetics of organoids using Seahorse","volume":"2","author":"Ludikhuize","year":"2021","journal-title":"STAR Protoc"},{"issue":"13","key":"10.1053\/j.ajkd.2026.01.021_bib33","doi-asserted-by":"crossref","DOI":"10.15252\/embj.2019104073","article-title":"A novel approach to measure mitochondrial respiration in frozen biological samples","volume":"39","author":"Acin-Perez","year":"2020","journal-title":"EMBO J"},{"key":"10.1053\/j.ajkd.2026.01.021_bib34","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.96926.4","article-title":"Mitochondrial respiration atlas reveals differential changes in mitochondrial function across sex and age","volume":"13","author":"Sarver","year":"2024","journal-title":"Elife"},{"issue":"8","key":"10.1053\/j.ajkd.2026.01.021_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.mocell.2024.100095","article-title":"Extracellular flux assay (seahorse assay): siverse applications in metabolic research across biological disciplines","volume":"47","author":"Yoo","year":"2024","journal-title":"Mol Cells"},{"issue":"12","key":"10.1053\/j.ajkd.2026.01.021_bib36","doi-asserted-by":"crossref","DOI":"10.1096\/fj.202301644RR","article-title":"A practical perspective on how to develop, implement, execute, and reproduce high-resolution respirometry experiments: the physiologist\u2019s guide to an Oroboros O2k","volume":"37","author":"Walsh","year":"2023","journal-title":"FASEB J"},{"issue":"1","key":"10.1053\/j.ajkd.2026.01.021_bib37","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-69867-2","article-title":"A method for assessing tissue respiration in anatomically defined brain regions","volume":"10","author":"Underwood","year":"2020","journal-title":"Sci Rep"},{"issue":"1","key":"10.1053\/j.ajkd.2026.01.021_bib38","doi-asserted-by":"crossref","first-page":"6531","DOI":"10.1038\/s41467-023-42188-4","article-title":"Endogenous renal adiponectin drives gluconeogenesis through enhancing pyruvate and fatty acid utilization","volume":"14","author":"Onodera","year":"2023","journal-title":"Nat Commun"},{"issue":"1","key":"10.1053\/j.ajkd.2026.01.021_bib39","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1038\/nm.3762","article-title":"Defective fatty acid oxidation in renal tubular epithelial cells has a key role in kidney fibrosis development","volume":"21","author":"Kang","year":"2015","journal-title":"Nat Med"},{"issue":"2","key":"10.1053\/j.ajkd.2026.01.021_bib40","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbabio.2021.148518","article-title":"Substrate-dependent differential regulation of mitochondrial bioenergetics in the heart and kidney cortex and outer medulla","volume":"1863","author":"Tomar","year":"2022","journal-title":"Biochim Biophys Acta Bioenerg"},{"issue":"11","key":"10.1053\/j.ajkd.2026.01.021_bib41","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1038\/s41684-024-01457-5","article-title":"A novel model of cardiovascular-kidney-metabolic syndrome combining unilateral nephrectomy and high-salt\u2013sugar\u2013fat diet in mice","volume":"53","author":"Carvalho","year":"2024","journal-title":"Lab Animal"},{"key":"10.1053\/j.ajkd.2026.01.021_bib42","series-title":"Mitochondrial Pathways and Respiratory Control, an Introduction to OXPHOS Analysis","author":"Gnaiger","year":"2020"},{"issue":"8","key":"10.1053\/j.ajkd.2026.01.021_bib43","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1681\/ASN.2019040415","article-title":"Renal-tubule epithelial cell nomenclature for single-cell RNA-sequencing studies","volume":"30","author":"Chen","year":"2019","journal-title":"J Am Soc Nephrol"},{"issue":"10","key":"10.1053\/j.ajkd.2026.01.021_bib44","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1038\/nrneph.2017.107","article-title":"Mitochondrial energetics in the kidney","volume":"13","author":"Bhargava","year":"2017","journal-title":"Nat Rev Nephrol"},{"issue":"1","key":"10.1053\/j.ajkd.2026.01.021_bib45","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1186\/s12877-023-04203-7","article-title":"Association of mitochondrial DNA copy number with chronic kidney disease in older adults","volume":"23","author":"Liu","year":"2023","journal-title":"BMC Geriatr"},{"issue":"1","key":"10.1053\/j.ajkd.2026.01.021_bib46","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-023-45404-9","article-title":"Mitochondrial DNA copy number is associated with incident chronic kidney disease and proteinuria in the AIDS linked to the intravenous experience cohort","volume":"13","author":"Tewari","year":"2023","journal-title":"Sci Rep"},{"issue":"23","key":"10.1053\/j.ajkd.2026.01.021_bib47","doi-asserted-by":"crossref","DOI":"10.3390\/ijms232315166","article-title":"Roles of mitochondrial DNA damage in kidney diseases: a new biomarker","volume":"23","author":"Feng","year":"2022","journal-title":"Int J Mol Sci"},{"issue":"1","key":"10.1053\/j.ajkd.2026.01.021_bib48","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1038\/s41467-019-09329-0","article-title":"Identification of serum metabolites associating with chronic kidney disease progression and anti-fibrotic effect of 5-methoxytryptophan","volume":"10","author":"Chen","year":"2019","journal-title":"Nat Commun"},{"issue":"11","key":"10.1053\/j.ajkd.2026.01.021_bib49","doi-asserted-by":"crossref","first-page":"4133","DOI":"10.1007\/s11010-021-04222-1","article-title":"NMR-based metabolomics associated with chronic kidney disease in humans and animals: a one health perspective","volume":"476","author":"Hunter","year":"2021","journal-title":"Mol Cell Biochem"},{"issue":"S1","key":"10.1053\/j.ajkd.2026.01.021_bib50","doi-asserted-by":"crossref","first-page":"S110","DOI":"10.1111\/hdi.12567","article-title":"HIF-prolyl hydroxylases as therapeutic targets in erythropoiesis and iron metabolism","volume":"21","author":"Haase","year":"2017","journal-title":"Hemodial Int"},{"issue":"4","key":"10.1053\/j.ajkd.2026.01.021_bib51","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0018398","article-title":"Circulating FGF21 levels are progressively increased from the early to end stages of chronic kidney diseases and are associated with renal function in Chinese","volume":"6","author":"Lin","year":"2011","journal-title":"PLoS One"},{"key":"10.1053\/j.ajkd.2026.01.021_bib52","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.ejim.2023.01.026","article-title":"Circulating GDF-15 in relation to the progression and prognosis of chronic kidney disease: a systematic review and dose-response meta-analysis","volume":"110","author":"Zhou","year":"2023","journal-title":"Eur J Int Med"},{"issue":"6","key":"10.1053\/j.ajkd.2026.01.021_bib53","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1007\/s40620-021-01020-2","article-title":"Urinary growth differentiation factor-15 (GDF15) levels as a biomarker of adverse outcomes and biopsy findings in chronic kidney disease","volume":"34","author":"Perez-Gomez","year":"2021","journal-title":"J Nephrol"},{"issue":"4","key":"10.1053\/j.ajkd.2026.01.021_bib54","doi-asserted-by":"crossref","first-page":"F387","DOI":"10.1152\/ajprenal.00285.2022","article-title":"The urinary proteome infers dysregulation of mitochondrial, lysosomal, and protein reabsorption processes in chronic kidney disease of unknown etiology (CKDu)","volume":"324","author":"Kolli","year":"2023","journal-title":"Am J Physiol Ren Physiol"},{"issue":"2","key":"10.1053\/j.ajkd.2026.01.021_bib55","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1093\/ckj\/sfx002","article-title":"Urinary peptide-based classifier CKD273: towards clinical application in chronic kidney disease","volume":"10","author":"Pontillo","year":"2017","journal-title":"Clin Kidney J"},{"issue":"24","key":"10.1053\/j.ajkd.2026.01.021_bib56","doi-asserted-by":"crossref","DOI":"10.1172\/JCI183984","article-title":"Attenuated kidney oxidative metabolism in young adults with type 1 diabetes","volume":"134","author":"Choi","year":"2024","journal-title":"J Clin Invest"},{"issue":"5","key":"10.1053\/j.ajkd.2026.01.021_bib57","doi-asserted-by":"crossref","DOI":"10.1172\/JCI164486","article-title":"SGLT2 inhibitors mitigate kidney tubular metabolic and mTORC1 perturbations in youth-onset type 2 diabetes","volume":"133","author":"Schaub","year":"2023","journal-title":"J Clin Invest"},{"issue":"2","key":"10.1053\/j.ajkd.2026.01.021_bib58","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1053\/j.ajkd.2018.06.032","article-title":"CKD due to a novel mitochondrial DNA mutation: a case report","volume":"73","author":"Fervenza","year":"2019","journal-title":"Am J Kidney Dis"},{"issue":"7970","key":"10.1053\/j.ajkd.2026.01.021_bib59","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1038\/s41586-023-05769-3","article-title":"An atlas of healthy and injured cell states and niches in the human kidney","volume":"619","author":"Lake","year":"2023","journal-title":"Nature"},{"issue":"8","key":"10.1053\/j.ajkd.2026.01.021_bib60","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.1038\/s41588-024-01802-x","article-title":"Single-cell multi-omic and spatial profiling of human kidneys implicates the fibrotic microenvironment in kidney disease progression","volume":"56","author":"Abedini","year":"2024","journal-title":"Nat Genet"},{"issue":"7","key":"10.1053\/j.ajkd.2026.01.021_bib61","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1681\/ASN.0000000000000343","article-title":"Association of integrated proteomic and metabolomic modules with risk of kidney disease progression","volume":"35","author":"Schlosser","year":"2024","journal-title":"J Am Soc Nephrol"},{"issue":"9","key":"10.1053\/j.ajkd.2026.01.021_bib62","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1007\/s00259-019-04359-8","article-title":"The next era of renal radionuclide imaging: novel PET radiotracers","volume":"46","author":"Werner","year":"2019","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"5","key":"10.1053\/j.ajkd.2026.01.021_bib63","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1002\/jmri.29000","article-title":"Noninvasive assessment of diabetic kidney disease with MRI: hype or hope?","volume":"59","author":"Zhao","year":"2024","journal-title":"J Magn Reson Imaging"},{"issue":"5","key":"10.1053\/j.ajkd.2026.01.021_bib64","doi-asserted-by":"crossref","DOI":"10.1111\/eci.13765","article-title":"Future of kidney imaging: functional magnetic resonance imaging and kidney disease progression","volume":"52","author":"Copur","year":"2022","journal-title":"Eur J Clin Invest"},{"issue":"4","key":"10.1053\/j.ajkd.2026.01.021_bib65","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1016\/j.kint.2017.10.020","article-title":"Reduced cortical oxygenation predicts a progressive decline of renal function in patients with chronic kidney disease","volume":"93","author":"Pruijm","year":"2018","journal-title":"Kidney Int"},{"issue":"11","key":"10.1053\/j.ajkd.2026.01.021_bib66","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1042\/CS20171490","article-title":"Probing insulin sensitivity in diabetic kidney disease: is there a stronger role for functional imaging?","volume":"132","author":"Granda","year":"2018","journal-title":"Clin Sci (Lond)"},{"issue":"4","key":"10.1053\/j.ajkd.2026.01.021_bib67","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1053\/j.semnuclmed.2021.12.003","article-title":"SPECT and PET radiotracers in renal imaging","volume":"52","author":"Werner","year":"2022","journal-title":"Semin Nucl Med"},{"key":"10.1053\/j.ajkd.2026.01.021_bib68","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.nucmedbio.2019.08.004","article-title":"PET [(11)C]acetate is also a perfusion tracer for kidney evaluation purposes","volume":"76-77","author":"Normand","year":"2019","journal-title":"Nucl Med Biol"},{"issue":"3","key":"10.1053\/j.ajkd.2026.01.021_bib69","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1053\/j.ajkd.2024.02.016","article-title":"Kidney energetics and cyst burden in autosomal dominant polycystic kidney disease: a pilot study","volume":"84","author":"Bjornstad","year":"2024","journal-title":"Am J Kidney Dis"},{"issue":"1","key":"10.1053\/j.ajkd.2026.01.021_bib70","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.kint.2020.02.024","article-title":"Positron emission tomography imaging of renal mitochondria is a powerful tool in the study of acute and progressive kidney disease models","volume":"98","author":"Saeki","year":"2020","journal-title":"Kidney Int"},{"issue":"1","key":"10.1053\/j.ajkd.2026.01.021_bib71","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1038\/s41467-017-01143-w","article-title":"Non-invasive assessment of hepatic mitochondrial metabolism by positional isotopomer NMR tracer analysis (PINTA)","volume":"8","author":"Perry","year":"2017","journal-title":"Nat Commun"},{"issue":"1","key":"10.1053\/j.ajkd.2026.01.021_bib72","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.cmet.2022.11.011","article-title":"Q-Flux: a method to assess hepatic mitochondrial succinate dehydrogenase, methylmalonyl-CoA mutase, and glutaminase fluxes in vivo","volume":"35","author":"Hubbard","year":"2023","journal-title":"Cell Metab"},{"issue":"1","key":"10.1053\/j.ajkd.2026.01.021_bib73","doi-asserted-by":"crossref","first-page":"8191","DOI":"10.1038\/s41598-018-24672-w","article-title":"Mitochondrial imaging in live or fixed tissues using a luminescent iridium complex","volume":"8","author":"Sorvina","year":"2018","journal-title":"Sci Rep"},{"issue":"11","key":"10.1053\/j.ajkd.2026.01.021_bib75","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1017\/S000711452000358X","article-title":"The effect of energy restriction on development and progression of chronic kidney disease: review of the current evidence","volume":"125","author":"Afsar","year":"2021","journal-title":"Br J Nutr"},{"issue":"12","key":"10.1053\/j.ajkd.2026.01.021_bib76","article-title":"Beneficial effects of caloric restriction on chronic kidney disease in rodent models: a meta-analysis and systematic review","volume":"10","author":"Xu X-m","year":"2015","journal-title":"PLoS One"},{"issue":"5","key":"10.1053\/j.ajkd.2026.01.021_bib77","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1681\/ASN.2015020132","article-title":"Food restriction ameliorates the development of polycystic kidney disease","volume":"27","author":"Warner","year":"2016","journal-title":"J Am Soc Nephrol"},{"issue":"10","key":"10.1053\/j.ajkd.2026.01.021_bib78","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1038\/nrm2249","article-title":"AMP-activated\/SNF1 protein kinases: conserved guardians of cellular energy","volume":"8","author":"Hardie","year":"2007","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"1","key":"10.1053\/j.ajkd.2026.01.021_bib79","doi-asserted-by":"crossref","first-page":"9062","DOI":"10.1038\/s41598-022-13054-y","article-title":"Renal protection induced by physical exercise may be mediated by the irisin\/AMPK axis in diabetic nephropathy","volume":"12","author":"Formigari","year":"2022","journal-title":"Sci Rep"},{"key":"10.1053\/j.ajkd.2026.01.021_bib80","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/s12986-019-0349-4","article-title":"Exercise training upregulates SIRT1 to attenuate inflammation and metabolic dysfunction in kidney and liver of diabetic db\/db mice","volume":"16","author":"Liu","year":"2019","journal-title":"Nutr Metab (Lond)"},{"issue":"7","key":"10.1053\/j.ajkd.2026.01.021_bib81","doi-asserted-by":"crossref","first-page":"795","DOI":"10.3390\/metabo13070795","article-title":"Effects of exercise on inflammatory markers in individuals with chronic kidney disease: a systematic review and meta-analysis","volume":"13","author":"Bai\u00e3o","year":"2023","journal-title":"Metabolites"},{"issue":"2","key":"10.1053\/j.ajkd.2026.01.021_bib82","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1056\/NEJMoa2204233","article-title":"Empagliflozin in patients with chronic kidney disease","volume":"388","author":"EMPA-KIDNEY Collaborative Group","year":"2023","journal-title":"N Engl J Med"},{"issue":"15","key":"10.1053\/j.ajkd.2026.01.021_bib83","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1056\/NEJMoa2024816","article-title":"Dapagliflozin in patients with chronic kidney disease","volume":"383","author":"Heerspink","year":"2020","journal-title":"N Engl J Med"},{"issue":"24","key":"10.1053\/j.ajkd.2026.01.021_bib84","doi-asserted-by":"crossref","first-page":"2295","DOI":"10.1056\/NEJMoa1811744","article-title":"Canagliflozin and renal outcomes in type 2 diabetes and nephropathy","volume":"380","author":"Perkovic","year":"2019","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1053\/j.ajkd.2026.01.021_bib85","doi-asserted-by":"crossref","first-page":"F767","DOI":"10.1152\/ajprenal.00565.2018","article-title":"Empagliflozin attenuates diabetic tubulopathy by improving mitochondrial fragmentation and autophagy","volume":"317","author":"Lee","year":"2019","journal-title":"Am J Physiol Ren Physiol"},{"key":"10.1053\/j.ajkd.2026.01.021_bib86","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellsig.2021.110206","article-title":"Dapagliflozin alleviates advanced glycation end product induced podocyte injury through AMPK\/mTOR mediated autophagy pathway","volume":"90","author":"Yang","year":"2022","journal-title":"Cell Signal"},{"issue":"3","key":"10.1053\/j.ajkd.2026.01.021_bib87","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.cmet.2020.06.020","article-title":"SGLT2 inhibition mediates protection from diabetic kidney disease by promoting ketone body-induced mTORC1 inhibition","volume":"32","author":"Tomita","year":"2020","journal-title":"Cell Metab"},{"issue":"1","key":"10.1053\/j.ajkd.2026.01.021_bib88","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1038\/s41581-021-00490-8","article-title":"Mineralocorticoid receptor antagonists in diabetic kidney disease\u2014mechanistic and therapeutic effects","volume":"18","author":"Barrera-Chimal","year":"2022","journal-title":"Nat Rev Nephrol"},{"issue":"11S","key":"10.1053\/j.ajkd.2026.01.021_bib89","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1681\/ASN.20223311S1880b","article-title":"SGLT2 inhibitors reduce urinary mitochondrial DNA copy number in both diabetic and non-diabetic CKD patients: SA-PO1000","volume":"33","author":"Lee","year":"2022","journal-title":"J Am Soc Nephrol"},{"issue":"2","key":"10.1053\/j.ajkd.2026.01.021_bib90","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1056\/NEJMoa2403347","article-title":"Effects of semaglutide on chronic kidney disease in patients with type 2 diabetes","volume":"391","author":"Perkovic","year":"2024","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1053\/j.ajkd.2026.01.021_bib91","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.kint.2023.09.029","article-title":"Glucagon-like peptide-1 receptor signaling modifies the extent of diabetic kidney disease through dampening the receptor for advanced glycation end products\u2013induced inflammation","volume":"105","author":"Sourris","year":"2024","journal-title":"Kidney Int"},{"issue":"11","key":"10.1053\/j.ajkd.2026.01.021_bib92","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.3390\/metabo13111121","article-title":"GLP-1 receptor agonist improves mitochondrial energy status and attenuates nephrotoxicity in vivo and in vitro","volume":"13","author":"Wang","year":"2023","journal-title":"Metabolites"},{"issue":"3","key":"10.1053\/j.ajkd.2026.01.021_bib93","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0193473","article-title":"GLP-1 receptor agonist ameliorates obesity-induced chronic kidney injury via restoring renal metabolism homeostasis","volume":"13","author":"Wang","year":"2018","journal-title":"PLoS One"},{"key":"10.1053\/j.ajkd.2026.01.021_bib94","article-title":"REMODELing mechanistic trials for kidney disease: a multimodal, tissue-centered approach to understand the renal mechanism of action of semaglutide","author":"Pruijm","year":"2025","journal-title":"Kidney Int"},{"issue":"11","key":"10.1053\/j.ajkd.2026.01.021_bib96","doi-asserted-by":"crossref","first-page":"2182","DOI":"10.1093\/ndt\/gfaf114","article-title":"Rationale, design and baseline characteristics of REMODEL, a mechanism-of-action trial with semaglutide in people with type 2 diabetes and chronic kidney disease","volume":"40","author":"Cherney","year":"2025","journal-title":"Nephrol Dial Transplant"},{"issue":"23","key":"10.1053\/j.ajkd.2026.01.021_bib97","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.1056\/NEJMoa2025845","article-title":"Effect of finerenone on chronic kidney disease outcomes in type 2 diabetes","volume":"383","author":"Bakris","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1053\/j.ajkd.2026.01.021_bib99","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2023.102946","article-title":"Non-steroidal mineralocorticoid receptor antagonist finerenone ameliorates mitochondrial dysfunction via PI3K\/Akt\/eNOS signaling pathway in diabetic tubulopathy","volume":"68","author":"Yao","year":"2023","journal-title":"Redox Biol"},{"issue":"11","key":"10.1053\/j.ajkd.2026.01.021_bib100","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1016\/S2213-8587(22)00243-1","article-title":"Effects of tirzepatide versus insulin glargine on kidney outcomes in type 2 diabetes in the SURPASS-4 trial: post-hoc analysis of an open-label, randomised, phase 3 trial","volume":"10","author":"Heerspink","year":"2022","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"6","key":"10.1053\/j.ajkd.2026.01.021_bib102","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1093\/ndt\/gfaf230","article-title":"Rationale, design, and baseline characteristics of the TRANSCEND-CKD trial of retatrutide in patients with chronic kidney disease","volume":"41","author":"Heerspink","year":"2026","journal-title":"Nephrol Dial Transplant"},{"issue":"1","key":"10.1053\/j.ajkd.2026.01.021_bib103","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/s12020-024-03998-8","article-title":"Comparison of the effects of liraglutide, tirzepatide, and retatrutide on diabetic kidney disease in db\/db mice","volume":"87","author":"Ma","year":"2025","journal-title":"Endocrine"},{"issue":"1","key":"10.1053\/j.ajkd.2026.01.021_bib104","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/nm.3761","article-title":"A rationally designed monomeric peptide triagonist corrects obesity and diabetes in rodents","volume":"21","author":"Finan","year":"2015","journal-title":"Nat Med"},{"issue":"3","key":"10.1053\/j.ajkd.2026.01.021_bib105","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.cmet.2023.12.024","article-title":"Downregulation of the kidney glucagon receptor, essential for renal function and systemic homeostasis, contributes to chronic kidney disease","volume":"36","author":"Wang","year":"2024","journal-title":"Cell Metab"},{"issue":"31","key":"10.1053\/j.ajkd.2026.01.021_bib106","doi-asserted-by":"crossref","first-page":"3710","DOI":"10.2174\/1381612824666181112112857","article-title":"The effects of coenzyme Q10 supplementation on metabolic profiles of patients with chronic kidney disease: a systematic review and meta-analysis of randomized controlled trials","volume":"24","author":"Bakhshayeshkaram","year":"2018","journal-title":"Curr Pharm Des"},{"key":"10.1053\/j.ajkd.2026.01.021_bib107","doi-asserted-by":"crossref","DOI":"10.1016\/j.arres.2022.100037","article-title":"Pharmacological significance of MitoQ in ameliorating mitochondria-related diseases","volume":"5","author":"Sulaimon","year":"2022","journal-title":"Adv Redox Res"},{"issue":"3","key":"10.1053\/j.ajkd.2026.01.021_bib108","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1038\/s42255-023-00761-7","article-title":"NAD(+) precursor supplementation prevents mtRNA\/RIG-I-dependent inflammation during kidney injury","volume":"5","author":"Doke","year":"2023","journal-title":"Nat Metab"},{"issue":"1","key":"10.1053\/j.ajkd.2026.01.021_bib109","doi-asserted-by":"crossref","first-page":"6398","DOI":"10.1038\/s41598-022-10476-6","article-title":"The significance of NAD + metabolites and nicotinamide N-methyltransferase in chronic kidney disease","volume":"12","author":"Takahashi","year":"2022","journal-title":"Sci Rep"},{"issue":"1","key":"10.1053\/j.ajkd.2026.01.021_bib110","doi-asserted-by":"crossref","first-page":"21","DOI":"10.3390\/cells12010021","article-title":"NAD+ metabolism and interventions in premature renal aging and chronic kidney disease","volume":"12","author":"Chanvillard","year":"2023","journal-title":"Cells"},{"issue":"3","key":"10.1053\/j.ajkd.2026.01.021_bib111","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.164626","article-title":"Mitochondrial and NAD+ metabolism predict recovery from acute kidney injury in a diverse mouse population","volume":"8","author":"Morel","year":"2023","journal-title":"JCI Insight"},{"issue":"11","key":"10.1053\/j.ajkd.2026.01.021_bib112","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.167274","article-title":"Randomized crossover clinical trial of coenzyme Q10 and nicotinamide riboside in chronic kidney disease","volume":"8","author":"Ahmadi","year":"2023","journal-title":"JCI Insight"},{"issue":"3","key":"10.1053\/j.ajkd.2026.01.021_bib113","doi-asserted-by":"crossref","first-page":"346","DOI":"10.2215\/CJN.0000000624","article-title":"A pilot trial of nicotinamide riboside and coenzyme Q10 on inflammation and oxidative stress in CKD","volume":"20","author":"Ahmadi","year":"2025","journal-title":"Clin J Am Soc Nephrol"},{"issue":"3","key":"10.1053\/j.ajkd.2026.01.021_bib114","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1681\/ASN.0000000000000294","article-title":"Renal mitochondrial ATP transporter ablation ameliorates obesity-induced CKD","volume":"35","author":"Permyakova","year":"2024","journal-title":"J Am Soc Nephrol"},{"issue":"3","key":"10.1053\/j.ajkd.2026.01.021_bib115","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.kint.2024.10.024","article-title":"Purinergic receptor P2X7 regulates interleukin-1\u03b1 mediated inflammation in chronic kidney disease in a reactive oxygen species-dependent manner","volume":"107","author":"Amini","year":"2025","journal-title":"Kidney Int"},{"issue":"3","key":"10.1053\/j.ajkd.2026.01.021_bib116","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.kint.2024.12.002","article-title":"Mitochondrial ROS connects P2X7-mediated Ca2+ influx with IL-1\u03b1 release by monocytes upon chronic tissue damage","volume":"107","author":"Miguel","year":"2025","journal-title":"Kidney Int"},{"issue":"5","key":"10.1053\/j.ajkd.2026.01.021_bib117","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1016\/j.kint.2025.01.024","article-title":"Fibroblast growth factor 23 and fibroblast growth factor receptor 4 promote cardiac metabolic remodeling in chronic kidney disease","volume":"107","author":"Fuchs","year":"2025","journal-title":"Kidney Int"},{"issue":"1","key":"10.1053\/j.ajkd.2026.01.021_bib118","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-49170-5","article-title":"Diffusion tensor imaging of the kidney: design and evaluation of a reliable processing pipeline","volume":"9","author":"Borrelli","year":"2019","journal-title":"Sci Rep"},{"issue":"1","key":"10.1053\/j.ajkd.2026.01.021_bib119","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1021\/acs.jmedchem.1c01660","article-title":"Development of mitochondria-targeted small-molecule dyes for myocardial PET and fluorescence bimodal imaging","volume":"65","author":"Zheng","year":"2022","journal-title":"J Med Chem"},{"issue":"12","key":"10.1053\/j.ajkd.2026.01.021_bib120","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.2967\/jnumed.119.226787","article-title":"Imaging of chemotherapy-induced acute cardiotoxicity with (18)F-labeled lipophilic cations","volume":"60","author":"McCluskey","year":"2019","journal-title":"J Nucl Med"},{"issue":"5","key":"10.1053\/j.ajkd.2026.01.021_bib121","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1053\/j.semnuclmed.2023.08.002","article-title":"[15O]H2O PET: potential or essential for molecular imaging?","volume":"54","author":"Slart","year":"2024","journal-title":"Semin Nucl Med"},{"issue":"6","key":"10.1053\/j.ajkd.2026.01.021_bib122","doi-asserted-by":"crossref","first-page":"2511","DOI":"10.1046\/j.1523-1755.2000.00110.x","article-title":"Renal blood flow measurement by positron emission tomography using 15O-labeled water","volume":"57","author":"Juillard","year":"2000","journal-title":"Kidney Int"}],"container-title":["American Journal of Kidney Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272638626009765?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272638626009765?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T08:42:15Z","timestamp":1787215335000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0272638626009765"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":118,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["S0272638626009765"],"URL":"https:\/\/doi.org\/10.1053\/j.ajkd.2026.01.021","relation":{},"ISSN":["0272-6386"],"issn-type":[{"value":"0272-6386","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mitochondrial Alterations and CKD: A Review","name":"articletitle","label":"Article Title"},{"value":"American Journal of Kidney Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.ajkd.2026.01.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 National Kidney Foundation, Inc. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}